Related Experiment Video
Updated: Sep 26, 2025

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping
Published on: February 22, 2018
Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial,
Petros Arsenos1, Konstantinos A Gatzoulis2, Dimitrios Tsiachris3
1First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration Hospital, Athens 11527, Attika, Greece.
Insights
This study introduces a two-step arrhythmic risk stratification (ARS) method using non-invasive factors and programmed ventricular stimulation (PVS) to identify high-risk patients with cardiomyopathy who may benefit from defibrillators.
Area of Science:
- Cardiology
- Electrophysiology
- Sudden Cardiac Death
Background:
- Arrhythmic sudden cardiac death (SCD) poses a significant risk in various cardiomyopathies, including ischemic (ICM), non-ischemic (NICM), and hypertrophic (HCM).
- Current risk stratification methods have limitations in accurately identifying patients who would benefit from interventions like implantable cardioverter-defibrillators (ICDs).
Purpose of the Study:
- To develop and present a novel two-step arrhythmic risk stratification (ARS) strategy.
- To improve the selection of intermediate-risk patients for further invasive assessment.
- To enhance the identification of high-risk patients with ICM, NICM, and HCM who would benefit from ICD implantation.
Main Methods:
- A two-step ARS approach was developed.
- Step 1 involves assessing seven non-invasive risk factors: late potentials, premature ventricular contractions, non-sustained ventricular tachycardia, heart rate turbulence, T wave alternans, heart rate variability, and prolonged QTc interval.
- Step 2 utilizes programmed ventricular stimulation (PVS) for intermediate-risk patients, with suggested PVS use for specific HCM subgroups.
Main Results:
- The proposed two-step ARS aims to refine the selection of patients for PVS.
- PVS is intended to identify inducible high-risk ICM and NICM patients for ICD therapy.
- For HCM, PVS incorporation aims to improve the sensitivity and specificity of risk assessment.
Conclusions:
- The presented two-step ARS, combining non-invasive markers and PVS, offers a refined approach to stratify arrhythmic risk in cardiomyopathy.
- This strategy may lead to more appropriate ICD implantation, particularly in ICM and NICM.
- For HCM, tailored PVS application could optimize risk stratification and patient management.
Abstract:
Annual arrhythmic sudden cardiac death ranges from 0.6% to 4% in ischemic cardiomyopathy (ICM), 1% to 2% in non-ischemic cardiomyopathy (NICM), and 1% in hypertrophic cardiomyopathy (HCM). Towards a more effective arrhythmic risk stratification (ARS) we hereby present a two-step ARS with the usage of seven non-invasive risk factors: Late potentials presence (≥ 2/3 positive criteria), premature ventricular contractions (≥ 30/h), non-sustained ventricular tachycardia (≥ 1episode/24 h), abnormal heart rate turbulence (onset ≥ 0% and slope ≤ 2.5 ms) and reduced deceleration capacity (≤ 4.5 ms), abnormal T wave alternans (≥ 65μV), decreased heart rate variability (SDNN < 70ms), and prolonged QTc interval (> 440 ms in males and > 450 ms in females) which reflect the arrhythmogenic mechanisms for the selection of the intermediate arrhythmic risk patients in the first step. In the second step, these intermediate-risk patients undergo a programmed ventricular stimulation (PVS) for the detection of inducible, truly high-risk ICM and NICM patients, who will benefit from an implantable cardioverter defibrillator. For HCM patients, we also suggest the incorporation of the PVS either for the low HCM Risk-score patients or for the patients with one traditional risk factor in order to improve the inadequate sensitivity of the former and the low specificity of the latter.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Dysrhythmias II: Classification of Tachyarrhythmias
Mitral Stenosis II: Clinical features and Diagnostic Tests